Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs

There are several routes of administration to the brain, including intraparenchymal, intraventricular, and subarachnoid injections. The blood-brain barrier (BBB) impedes the permeation and access of most drugs to the central nervous system (CNS), and consequently, many neurological diseases remain u...

Descripción completa

Detalles Bibliográficos
Autores principales: Mignani, Serge, Shi, Xiangyang, Karpus, Andrii, Majoral, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548078/
https://www.ncbi.nlm.nih.gov/pubmed/33069435
http://dx.doi.org/10.1016/j.ejmech.2020.112905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548078/
https://www.ncbi.nlm.nih.gov/pubmed/33069435
http://dx.doi.org/10.1016/j.ejmech.2020.112905

Ejemplares similares